Actively Recruiting
Nutritional Management to Support Immune Health and Reduce Side Effects During Concurrent Chemoradiotherapy in Adults With Nasopharyngeal Carcinoma
Led by Jiangxi Provincial Cancer Hospital · Updated on 2025-07-25
109
Participants Needed
1
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Nasopharyngeal carcinoma NPC is a cancer that develops in the lining of the nasopharynx. Malnutrition is a common complication in NPC patients, especially those receiving concurrent chemoradiotherapy, which can affect their prognosis. This trial is studying the impact of nutritional management on immune status, weight, treatment side effects, and quality of life in NPC patients undergoing concurrent chemoradiotherapy. Participants in this study will receive an immune-enhancing oral nutritional supplement called Rapid glitter starting from the first day of their radiotherapy. The study is designed to assess how this nutritional support affects patients during their chemoradiotherapy treatment course. The study is non-randomized and involves giving all patients the supplement while monitoring their condition. Throughout the treatment period, researchers will evaluate patients immune nutritional status at various points. They will track changes in immune cell populations, weight, treatment-related toxicities, and quality of life. The primary outcome is the decrease in certain immune cell subsets after 2 weeks, with secondary outcomes including weight change at 2 weeks and disease-free survival over 3 years. Participants will be involved in regular assessments during and after treatment to monitor these outcomes.
CONDITIONS
Brief Title
Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
Research Team
Y
Yong Su, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here